Cytori Therapeutics, Inc. (CYTX)

[highjaxx]

Upcoming Near Term Catalysts:

-Evaluate and release 24-week data from 94 patient US pilot/phase IIb ACT-OA trial (anticipated Q1 2016) and identify partner for late stage US clinical development
-Complete enrollment of US STAR trial (anticipated mid 2016) for scleroderma hand dysfunction
Complete enrollment of EU pivotal/phase III SCLERADEC-II trial (anticipated mid 2016) for scleroderma hand dysfunction
-Complete enrollment of Japanese pivotal/phase III ADRESU trial (anticipated 2017) for stress urinary incontinence
-Work with FDA to plan a burn wound therapy trial related to contract with BARDA (anticipated in 2016)